(Q43105968)

14 November 2017

title

Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis (English)

1 reference

14 November 2017

Mark S Geier

0 references

Ruth J Lindsay

1 reference

14 November 2017

Roger Yazbeck

series ordinal

1 reference

14 November 2017

Ross N Butler

series ordinal

1 reference

14 November 2017

Gordon S Howarth

series ordinal

1 reference

14 November 2017

publication date

9 April 2010

1 reference

British Journal of Nutrition

14 November 2017

published in

1 reference

14 November 2017

volume

104

1 reference

14 November 2017

1 reference

14 November 2017

page(s)

513-519

1 reference

Intestinal epithelial cell proliferation is dependent on the site of massive small bowel resection.

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Antagonism of croton oil inflammation by topical emu oil in CD-1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Influence of two dietary fats on the composition of emu oil and meat

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Emu oil(s): a source of non-toxic transdermal anti-inflammatory agents in aboriginal medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Exposure of oral mucosa to bioactive milk factors reduces severity of chemotherapy-induced mucositis in the hamster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Gastrointestinal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Gastrointestinal mucositis: a new biological model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Treatment of mucositis, including new medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Pathobiology of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Comparison of the antioxidant properties of emu oil with other avian oils

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

21 January 2018

Vitamin E and apoptosis

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Anti-inflammatory effects of alpha-tocopherol

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Optimization of the non-invasive 13C-sucrose breath test in a rat model of methotrexate-induced mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

A novel breath test for the non-invasive assessment of small intestinal mucosal injury following methotrexate administration in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Modification of glucocorticoid-induced changes in myofibrillar protein turnover in rats by protein and energy deficiency as assessed by urinary excretion of Ntau-methylhistidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Intestinal mucosal adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

Anti-inflammatory activity of emu oils in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

7 January 2021

The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

7 January 2021

Velafermin improves gastrointestinal mucositis following irinotecan treatment in tumor-bearing DA rats

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

7 January 2021

The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

7 January 2021

Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

7 January 2021

Whole population cell kinetics of mouse duodenal, jejunal, ileal, and colonic epithelia as determined by radioautography and flow cytometry

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

7 January 2021

Insulin-like growth factor-I and the gastrointestinal system: therapeutic indications and safety implications

1 reference

https://api.crossref.org/works/10.1017%2FS000711451000084X

7 January 2021

10.1017/S000711451000084X

Identifiers

DOI

1 reference

14 November 2017

1 reference